blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2366709

EP2366709 - Tumor vaccination involving a humoral immune response against self-proteins [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.08.2012
Database last updated on 06.07.2024
Most recent event   Tooltip17.08.2012Application deemed to be withdrawnpublished on 19.09.2012  [2012/38]
Applicant(s)For all designated states
BioNTech AG
Philipp-von-Zabern-Platz 1
55116 Mainz / DE
For all designated states
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Langenbeckstraße 1
55131 Mainz / DE
[2011/38]
Inventor(s)01 / Klamp, Thorsten
Albinstr. 11
55116 Mainz / DE
02 / Sahin, Ugur
Philipp-Zabern-Platz 1
55116 Mainz / DE
03 / Türeci, Özlem
Philipp-Zabern-Platz 1
55116 Mainz / DE
04 / Koslowski, Michael
Autogenstr. 50
65933 Frankfurt/Main / DE
05 / Hiller, Thomas
An der Allee 82
55122 Mainz / DE
06 / Schumacher, Jens
Keplerstr. 54
69120 Heidelberg / DE
 [2011/38]
Representative(s)Schnappauf, Georg, et al
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[N/P]
Former [2011/38]Schnappauf, Georg, et al
Dr. Volker Vossius Patent- und Rechtsanwaltskanzlei Geibelstrasse 6
81679 München / DE
Application number, filing date10002775.416.03.2010
[2011/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2366709
Date:21.09.2011
Language:EN
[2011/38]
Search report(s)(Supplementary) European search report - dispatched on:EP07.10.2010
ClassificationIPC:C07K14/02, A61K39/29, C07K14/47
[2011/38]
CPC:
C07K14/4748 (EP); A61K39/001102 (EP,US); C07K14/005 (EP);
C12N7/00 (EP); A61K2039/5256 (EP); A61K2039/6075 (EP);
C07K2319/00 (EP); C12N2730/10122 (EP); C12N2730/10123 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/38]
Extension statesALNot yet paid
BANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:Tumorvakzinierung, die eine humorale Immunantwort gegen Selbstproteine beinhaltet[2011/38]
English:Tumor vaccination involving a humoral immune response against self-proteins[2011/38]
French:Vaccination anti-tumeur impliquant une réponse immunitaire humorale contre les protéines endogènes[2011/38]
Examination procedure22.03.2012Application deemed to be withdrawn, date of legal effect  [2012/38]
02.05.2012Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2012/38]
Fees paidPenalty fee
Additional fee for renewal fee
31.03.201203   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9735008  (US HEALTH [US], et al) [Y] 1-18 * the whole document *;
 [A]WO2004084940  (CYTOS BIOTECHNOLOGY AG [CH], et al) [A] 1-18 * page 6, paragraph 1; claims 1,13,14,33 *;
 [A]EP1997832  (GANYMED PHARMACEUTICALS AG [DE], et al) [A] 1-18 * the whole document *;
 [A]WO2009033276  (UNIV LAVAL [CA], et al) [A] 1-18 * paragraph [0002] * * paragraph [0104] - paragraph [0105] *;
 [Y]  - SAHIN UGUR ET AL, "Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 DEC 2008 LNKD- PUBMED:19047087, (20081201), vol. 14, no. 23, ISSN 1078-0432, pages 7624 - 7634, XP002588324 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-08-1547
 [A]  - BIRAGYN A ET AL, "E. COLI EXPRESSED LYMPHOMA IG IDIOTYPE ANTIGEN FUSION PROTEINS AND CHIMERIC HBCAG PARTICLES BEARING TUMOR EPITOPES", CANCER BIOTHERAPY, XX, XX, (19950303), vol. 10, no. 1, page 85, XP002035977 [A] 1-18 * the whole document *
 [A]  - PUMPENS P ET AL, "EVALUATION OF HBS, HBC, AND FRCP VIRUS-LIKE PARTICLES FOR EXPRESSION OF HUMAN PAPILLOMAVIRUS 16 E7 ONCOPROTEIN EPITOPES", INTERVIROLOGY, KARGER, XX LNKD- DOI:10.1159/000050084, (20020101), vol. 45, no. 1, ISSN 0300-5526, pages 24 - 32, XP008026494 [A] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1159/000050084
 [A]  - FAGAN E A ET AL, "Hepatitis B vaccine: immunogenicity and follow-up including two year booster doses in high-risk health care personnel in a London teaching hospital.", JOURNAL OF MEDICAL VIROLOGY JAN 1987 LNKD- PUBMED:2947973, (198701), vol. 21, no. 1, ISSN 0146-6615, pages 49 - 56, XP002588326 [A] 1-18 * the whole document *
 [Y]  - BIRKS DIANE K ET AL, "Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors.", BRAIN PATHOLOGY (ZURICH, SWITZERLAND) JAN 2010 LNKD- PUBMED:19220299, (201001), vol. 20, no. 1, ISSN 1750-3639, pages 140 - 150, XP002602203 [Y] 1-7,9-18 * the whole document *

DOI:   http://dx.doi.org/10.1111/J.1750-3639.2008.00255.X
 [Y]  - DONG XUE-YUAN ET AL, "Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER 1 MAY 2008 LNKD- PUBMED:18183594, (20080501), vol. 122, no. 9, ISSN 1097-0215, pages 2038 - 2043, XP002602204 [Y] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1002/IJC.23341
by applicantWO9633739
 DE102008061522
    - SLAMON, D. J.; GODOLPHIN, W.; JONES, L. A.; HOLT, J. A.; WONG, S. G.; KEITH, D. E.; LEVIN, W. J.; STUART, S. G.; UDOVE, J.; ULLRIC, SCIENCE, (1989), vol. 244, pages 707 - 712
    - SO ET AL., MOL. CELLS, (1997), vol. 7, pages 178 - 186
    - KRIEG ET AL., NATURE, (1995), vol. 374, pages 546 - 549
    - S. M. BERGE ET AL., "Pharmaceutical Salts", J. PHARM. SCI., (1977), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560

DOI:   http://dx.doi.org/10.1002/jps.2600660104
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.